Table 1.
Clinicopathological characteristics.
| Characteristics | Number of patients (n) | SF3B4 expression | ||
|---|---|---|---|---|
| Low (%) | High (%) | P value | ||
| No. of patients | 53 | 27 | 26 | |
| Age | ||||
| ≤63 | 27 | 13 (48.15) | 14 (51.85) | 0.678 |
| >63 | 26 | 14 (53.85) | 12 (46.15) | |
| Gender | ||||
| Male | 39 | 20 (51.28) | 19 (48.72) | 0.934 |
| Female | 14 | 7 (50.00) | 7 (50.00) | |
| Tumor size (cm) | ||||
| ≤5 | 35 | 16 (45.71) | 19 (54.29) | 0.288 |
| >5 | 18 | 11 (61.11) | 7 (38.89) | |
| pT status | ||||
| pT1–pT2 | 31 | 12 (38.71) | 19 (61.29) | 0.034 |
| pT3–pT4 | 22 | 15 (68.18) | 7 (31.82) | |
| pN status | ||||
| pN0 | 30 | 11 (36.67) | 19 (63.33) | 0.018 |
| pN1–pN3 | 23 | 16 (69.57) | 7 (30.43) | |
| TNM stage | ||||
| I–II | 33 | 13 (39.39) | 20 (60.61) | 0.031 |
| III–IV | 20 | 14 (70.00) | 6 (30.00) | |
| Furhman Grade | ||||
| G1/G2 | 29 | 10 (34.48) | 19 (65.52) | 0.008 |
| G3/G4 | 24 | 17 (70.83) | 7 (29.17) | |